Skip to main content
Log in

MicroRNAs and cancer

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

MicroRNAs (miRNAs) belong to a class of noncoding, regulatory RNAs that are involved in oncogenesis and show remarkable tissue specificity. miRNAs are approximately 22 nt non-coding RNAs, which regulate gene expression in a sequence-specific manner via translational inhibition or messenger RNA (mRNA) degradation, thus affecting various cellular processes. Since the discovery of their fundamental mechanisms of action, the field of miRNAs has opened a new era in the understanding of small noncoding RNAs. Recent evidence has shown that miRNA controls cell growth, apoptosis, and differentiation. Cancer is a complex genetic disease caused by abnormalities in gene structure and expression, moreover, miRNA expression correlates with cancers and could have a crucial function in tumor progression. Bioinformatic data indicate that each miRNA can control hundreds of target genes, but identification of the accurate miRNA targets will be crucial to exploit the emerging knowledge of miRNA contribution to cancer process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lee RC, Feinbaum RL, et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993, 75: 843–854.

    Article  CAS  PubMed  Google Scholar 

  2. Lau NC, Lim LP, Weinstein EG, et al. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science, 2001, 294: 858–862.

    Article  CAS  PubMed  Google Scholar 

  3. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science, 2001, 294: 862–864.

    Article  CAS  PubMed  Google Scholar 

  4. Karginov FV, Conaco C, Xuan Z, et al. A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci U S A, 2007, 104: 19291–19296.

    Article  CAS  PubMed  Google Scholar 

  5. Cai X, Hagedorn CH, Cullen BR, et al. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA, 2004, 10: 1957–1966.

    Article  CAS  PubMed  Google Scholar 

  6. Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J, 2004, 23: 4051–4060.

    Article  CAS  PubMed  Google Scholar 

  7. Kim VN, Nam JW. Genomics of microRNA. Trends Genet, 2006, 22: 165–173.

    Article  CAS  PubMed  Google Scholar 

  8. Jay C, Nemunaitis J, Chen P, et al. miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol, 2007, 26: 293–300.

    Article  CAS  PubMed  Google Scholar 

  9. Doench JG, Petersen CP, Sharp PA. SiRNAs can function as miRNAs. Genes Dev, 2003, 17: 438–442.

    Article  CAS  PubMed  Google Scholar 

  10. Doench JG, Sharp PA. Specificity of microRNA target selection in translational repression. Genes Dev, 2004, 18: 504–511.

    Article  CAS  PubMed  Google Scholar 

  11. Zhu QS, Wang XC. Gene silencing: Principle and method. Kunming: Yunnan Science Technology Press, 2005. 54–79.

    Google Scholar 

  12. Zhang L, Huang J, Yang N, et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A, 2006, 103: 9136–9141.

    Article  CAS  PubMed  Google Scholar 

  13. Wiemer EA. The role of microRNAs in cancer: no small matter. Eur J Cancer, 2007, 43: 1529–1544.

    Article  CAS  PubMed  Google Scholar 

  14. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A, 2002, 99: 15524–15529.

    Article  CAS  PubMed  Google Scholar 

  15. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature, 2005, 435: 834–838.

    Article  CAS  PubMed  Google Scholar 

  16. Ma L, Teruya-Feldstein J, Robert A. et al. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 2007, 449: 682–688.

    Article  CAS  PubMed  Google Scholar 

  17. Saito Y, Liang G, Egger G, et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell, 2006, 9: 435–443.

    Article  CAS  PubMed  Google Scholar 

  18. He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature, 2005, 435: 828–833.

    Article  CAS  PubMed  Google Scholar 

  19. Hammond SM. MicroRNAs as oncogenes. Curr Opin Genet Dev, 2006, 16: 4–9.

    Article  CAS  PubMed  Google Scholar 

  20. McManus MT. MicroRNAs and cancer. Semin Cancer Biol, 2003, 13: 253–258.

    Article  CAS  PubMed  Google Scholar 

  21. Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 1998, 391: 806–811.

    Article  CAS  PubMed  Google Scholar 

  22. Lv W, Zhang C, Hao J. RNAi technology: A revolutionary tool for the colorectal cancer therapeutics. World J Gastroenterol, 2006, 12: 4636–4639.

    CAS  PubMed  Google Scholar 

  23. Zhang M, Zhang X, Bai CX, et al. Silencing the epidermal growth factor receptor gene with RNAi may be developed as a potential therapy for non small cell lung cancer. Genet Vaccines Ther, 2005, 3: 5.

    Article  PubMed  Google Scholar 

  24. Mathupala SP, Mittal S, Guthikonda M, et al. MicroRNA and brain tumors: a cause and a cure? DNA Cell Biol, 2007, 26: 301–310.

    Article  CAS  PubMed  Google Scholar 

  25. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A, 2004, 101: 2999–3004.

    Article  CAS  PubMed  Google Scholar 

  26. Sontheimer EJ, Carthew RW. Silence from within: endogenous siRNAs and miRNAs. Cell, 2005, 122: 9–12.

    Article  CAS  PubMed  Google Scholar 

  27. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116: 281–297.

    Article  CAS  PubMed  Google Scholar 

  28. Kusenda B, Mraz M, Mayer J, et al. MicroRNA biogenesis, functionality and cancer relevance. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2006, 150: 205–215.

    CAS  PubMed  Google Scholar 

  29. Yang N, Coukos G, Zhang L. MicroRNA epigenetic alterations in human cancer: One step forward in diagnosis and treatment. Int J Cancer, 2008, 122, 963–968.

    Article  CAS  PubMed  Google Scholar 

  30. Berezikov E, Guryev V, van de Belt J, et al. Phylogenetic shadowing and computational identification of human microRNA genes. Cell, 2005, 120: 21–24.

    Article  CAS  PubMed  Google Scholar 

  31. Barbarott E, Schmittgen TD, Calin GA. MicroRNAs and cancer: Profile, profile, profile. Int J Cancer, 2008, 122: 969–977.

    Article  Google Scholar 

  32. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res, 2006, 66: 7390–7394.

    Article  CAS  PubMed  Google Scholar 

  33. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A, 2005, 102: 13944–13949.

    Article  CAS  PubMed  Google Scholar 

  34. Michael MZ, O’Connor SM, van Holst Pellekaan NG, et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res, 2003, 1: 882–891.

    CAS  PubMed  Google Scholar 

  35. Suh MR, Lee Y, Kim JY, et al. Human embryonic stem cells express a unique set of microRNAs. Dev Biol, 2004, 270: 488–498.

    Article  CAS  PubMed  Google Scholar 

  36. Thomson JM, Parker J, Perou CM, et al. A custom microarray platform for analysis of microRNA gene expression. Nat Methods, 2004, 1: 47–53.

    Article  CAS  PubMed  Google Scholar 

  37. Costinean S, Zanesi N, Pekarsky Y, et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice. Proc Natl Acad Sci U S A, 2006, 103: 7024–7029.

    Article  CAS  PubMed  Google Scholar 

  38. Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol, 2007, 23: 175–205.

    Article  CAS  PubMed  Google Scholar 

  39. Johnson SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 microRNA family. Cell, 2005, 120: 635–647.

    Article  CAS  PubMed  Google Scholar 

  40. O’Donnel KA, Wentzel EA, Zeller KI, et al. c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 2005, 435: 839–843.

    Article  Google Scholar 

  41. Esquela-Kerscher A, Slack FJ. Oncomirs — microRNAs with a role in cancer. Nat Rev Cancer, 2006, 6: 259–269.

    Article  CAS  PubMed  Google Scholar 

  42. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res, 2005, 65: 6029–6033.

    Article  CAS  PubMed  Google Scholar 

  43. Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 2005, 65: 7065–7070.

    Article  CAS  PubMed  Google Scholar 

  44. Voorhoeve PM, le Sage C, Schrier M, et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell, 2006, 124: 1169–1181.

    Article  CAS  PubMed  Google Scholar 

  45. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer, 2006, 6: 857–866.

    Article  CAS  PubMed  Google Scholar 

  46. Yanaihara N, Caplen N, Bowman E. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 2006, 9: 189–198.

    Article  CAS  PubMed  Google Scholar 

  47. Zhu S, Wu H, Wu F, et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res, 2008, 18: 350–359.

    Article  CAS  PubMed  Google Scholar 

  48. Huang Q, Gumireddy K, Schrier M, et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol, 2008, 10: 202–210.

    Article  CAS  PubMed  Google Scholar 

  49. Tavazoie SF, Alarcón C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature, 2008, 451: 147–152.

    Article  CAS  PubMed  Google Scholar 

  50. Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 2006, 9: 189–198.

    Article  CAS  PubMed  Google Scholar 

  51. Yu SL, Chen HY, Yang PC, et al. Unique MicroRNA Signature and Clinical Outcome of Cancers. DNA and Cell BIO, 2007, 26: 283–292.

    Article  CAS  Google Scholar 

  52. Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol, 2008, 141: 672–675.

    Article  PubMed  Google Scholar 

  53. Chen X, Ba Y, Ma L. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 2008, 18: 997–1006.

    Article  CAS  PubMed  Google Scholar 

  54. Lee, NS., Dohjima, T, Bauer, G, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol, 2002, 20: 500–505.

    CAS  PubMed  Google Scholar 

  55. Duxbury MS, Ito H, Zinner MJ, et al. EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma. Oncogene, 2004, 23: 1448–1456.

    Article  CAS  PubMed  Google Scholar 

  56. Kamath RS, Fraser AG, Dong Y, et al. Systematic functional analysis of Caenorhabditis elegans genome using RNAi. Nature, 2003, 421: 231–237.

    Article  CAS  PubMed  Google Scholar 

  57. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature, 2004, 431: 371–378.

    Article  CAS  PubMed  Google Scholar 

  58. Masiero M, Nardo G, Indraccolo S, et al. RNA interference: implications for cancer treatment. Mol Aspects Med, 2007, 28: 143–166.

    Article  CAS  PubMed  Google Scholar 

  59. Jin Y, Tian X, Shang Y, et al. Inhibition of DLC-1 gene expression by RNA interference in the colon cancer LoVo cell line. Oncol Rep, 2008, 19: 669–674.

    CAS  PubMed  Google Scholar 

  60. Wu WD, Fang CH, Yang ZX, et al. Effects of RNA interference on epidermal growth factor receptor expression in breast cancer cells: a study in tumor-bearing nude mice. J South Med Univ (Chinese), 2008, 28: 60–64.

    CAS  Google Scholar 

  61. Tong AW, Nemunaitis J. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther, 2008, 15: 341–355.

    Article  CAS  PubMed  Google Scholar 

  62. Krützfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature, 2005, 438: 685–689.

    Article  PubMed  Google Scholar 

  63. Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab, 2006, 3: 87–98.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qishun Zhu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xiao, L., Wu, Z., Feng, R. et al. MicroRNAs and cancer. Chin. -Ger. J. Clin. Oncol. 9, 547–554 (2010). https://doi.org/10.1007/s10330-010-0648-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-010-0648-8

Key words

Navigation